LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX
· Real-Time Price · USD
1.58
-0.01 (-0.51%)
At close: Sep 26, 2025, 11:07 AM
-0.51% (1D)
Bid | 1.57 |
Market Cap | 41.69M |
Revenue (ttm) | 4.99M |
Net Income (ttm) | -28.38M |
EPS (ttm) | -1.06 |
PE Ratio (ttm) | -1.5 |
Forward PE | -3.06 |
Analyst | Hold |
Dividends | n/a |
Ask | 1.59 |
Volume | 71,945 |
Avg. Volume (20D) | 193,180 |
Open | 1.57 |
Previous Close | 1.59 |
Day's Range | 1.57 - 1.59 |
52-Week Range | 0.85 - 2.09 |
Beta | 0.49 |
Ex-Dividend Date | n/a |
About LVTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LVTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LVTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+7.89%
LAVA Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
7 months ago
+42.55%
Lava Therapeutics shares are trading higher after the company announced the evaluation of strategic options.